Description:
Tigecycline, A glycylcycline antibiotic, used to treat infection by drug resistant bacteria such as
Staphylococcus aureus (Staph aureus) and Acinetobacter baumannii.
Function:
Tigecycline is used to treat different kinds of bacterial infections, including complicated skin
and structure infections, complicated intra-abdominal infections and community-acquired
bacterial pneumonia. The spectrum of activity of tigecycline is discussed below.
Tigecycline can treat complicated skin and structure infections caused by; Escherichia
coli, vancomycin-susceptible Enterococcus faecalis, methicillin-resistant Staphylococcus
aureus (MRSA), Streptococcus agalactiae, Streptococcus anginosus grp., Streptococcus
pyogenes, Enterobacter cloacae, Klebsiella pneumoniae, and Bacteroides fragilis.
Tigecycline is indicated for treatment of complicated intra-abdominal infections caused
by; Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca,
Klebsiella pneumoniae, vancomycin-susceptible Enterococcus faecalis, methicillin-resistant
Staphylococcus aureus (MRSA), Streptococcus anginosus grp., Bacteroides fragilis,
Bacteroides thetaiotaomicron, Bacteroides uniformis, Bacteroides vulgatus, Clostridium
perfringens, and Peptostreptococcus micros.
Tigecycline may be used for treatment of community-acquired bacterial pneumonia caused
by; penicillin susceptible Streptococcus pneumoniae, Haemophilus influenzae that does not
produce Beta-lactamase and Legionella pneumophila.